After it is grafted into the bone, the innovative material is absorbed and replaced during regeneration. With its demonstrated efficacy, OSferion holds enormous promise in improving both treatment and the patient's quality of life. Marketing will focus on OSferion's clear competitive advantages. Plans include exhibits at major conferences in orthopedic medicine, beginning with the 72nd Annual Meeting of the Japanese Orthopaedic Association on April 8 at Pacifico Yokohama. Major Clinical Advantages Improving the Patient's Quality of Life OSferion eliminates the need for bone autotransplantation or minimizes the amount of bone harvested from another part of the body.
Treatment includes younger patients who are still growing.
During the recovery process, OSferion does not interfere with correcting any abnormalities at the graft point. It also facilitates accurate X-ray examinations since only minimal residual material remains after natural bone replacement. Osteoconduction is the ability to promote bone regeneration by serving as a scaffolding for the growth of new tissue. Conventional therapies sometimes require autotransplantation of bone from another part of the body or harvesting to create a mixture of natural bone and an artificial material. OSferion eases the trauma of these procedures by eliminating the need for autotransplantation or minimizing the amount taken during harvesting.